Ebola’s Lost Blood: Row over Samples Flown Out of Africa as ‘Big Pharma’ Set to Cash In

February 6, 2019

(The Telegraph) – A row is simmering over the ownership of thousands of Ebola blood samples taken from patients during the 2014-16 epidemic in West Africa and now held in secretive laboratories around the world. The samples have enormous value to researchers involved in creating new vaccines and medicines but also to defence facilities such as Porton Down in the UK where research on bio-chemical agents and their antidotes is conducted. Now several African scientists and Ebola survivors accuse the laboratories of biological asset stripping.

Recommended Reading